GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 287 filers reported holding GW PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $656,000 | -28.7% | 6,272 | -21.6% | 0.00% | 0.0% |
| Q3 2019 | $920,000 | -21.3% | 8,002 | +18.0% | 0.00% | 0.0% |
| Q2 2019 | $1,169,000 | -17.2% | 6,780 | -19.1% | 0.00% | -50.0% |
| Q1 2019 | $1,412,000 | +73.0% | 8,378 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $816,000 | -28.9% | 8,378 | +26.0% | 0.00% | 0.0% |
| Q3 2018 | $1,148,000 | +23.7% | 6,648 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $928,000 | +217.8% | 6,648 | +156.3% | 0.00% | – |
| Q1 2018 | $292,000 | -14.6% | 2,594 | 0.0% | 0.00% | – |
| Q4 2017 | $342,000 | +134.2% | 2,594 | +114.0% | 0.00% | – |
| Q1 2017 | $146,000 | +57.0% | 1,212 | +45.5% | 0.00% | – |
| Q4 2016 | $93,000 | -33.6% | 833 | -21.2% | 0.00% | – |
| Q3 2016 | $140,000 | +109.0% | 1,057 | +44.8% | 0.00% | – |
| Q2 2016 | $67,000 | – | 730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |